Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia.
Carlens
S
S
Dept of Transplantation Surgery, Huddinge University Hospital, Sweden.
Ringdén
O
O
Remberger
M
M
Mattsson
J
J
Aschan
J
J
Hägglund
H
H
Ljungman
P
P
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D016026:Bone Marrow Transplantation / Q000401:mortality / Q000502:physiology*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D018572:Disease-Free Survival; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007938:Leukemia / Q000401:mortality / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009679:Nuclear Family; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D012008:Recurrence; D012189:Retrospective Studies; D012307:Risk Factors
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide